Veverimer FDA Approval Status
FDA Approved: No
Generic name: veverimer
Company: Tricida, Inc.
Treatment for: Metabolic Acidosis
Veverimer (TRC101) is a non-absorbed, orally-administered polymer in development for the treatment of metabolic acidosis in patients with chronic kidney disease (CKD).
Development Timeline for veverimer
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.